The development in healthcare infrastructure induces many factors such as growing concern for aesthetic treatments, increasing awareness towards minimally or non-invasive procedures, insurance penetration, affordability of the population, rising income, the heightened average life span of the populace, and encouraging medical tourism flow, among others. The acceleration in technology development in the healthcare sector significantly affects the development of healthcare infrastructure. The advancement in technology of aesthetic devices is assisting for better appearance.
Access Full Report @ https://www.databridgemarketresearch.com/pt/reports/global-aesthetic-dermatology-market
The global aesthetic dermatology market is expected to reach USD 14,935.16 million by 2029 from USD 7.068.42 million in 2021, growing at a CAGR of 10.2% in the forecast period of 2022 to 2029. An increasing trend in population will reduce patients who stay in hospitals healthcare, resulting in a growing number of surgeries performed. Minimally invasive surgery has a very high patient-acceptance growth rate.
The growing desire for one's appearance across the world will drive the market's growth rate
Aesthetic treatments have revolutionized the entire beauty industry by providing a minimally invasive or non-invasive body-enhancing approach. The aesthetic surgery helps get the desired appearance for males and females who are not satisfied with their appearance. Various factors impel the growth of the aesthetic dermatology market, such as increasing desire to improve one's appearance, growing awareness for non-invasive procedures, and media influencers, among others.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Medicines and Devices), Surgery Type (Minimally Invasive and Non-Invasive), Treatment Type (Face Treatment and Body Treatment), Application (Skin Rejuvenation, Skin Resurfacing, Skin Tightening, Hair Removal, Pigmented & Vascular Lesions, Tattoo Removal, Scar, Acne, Dyschromia, Skin Tags, Psoriasis, Warts, Hyperhidrosis, Moles and Freckles and Others), Gender (Female and Male), End User (Hospitals, Dermatology Clinics, Surgical Centres, Spa Clinics and Others), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
AbbVie Inc. (U.S.), Henry Schein, Inc. (U.S.), Merz Pharma (Germany), Cutera (U.S.), Cynosure. Inc. (A Subsidiary of Hologic, Inc.) (U.S.), Candela Medical (U.S.), Bausch Health Companies Inc. (Canada), Evolus, Inc. (U.S.), Medytox (South Korea), LUTRONIC (South Korea), HUGEL, Inc. (South Korea), El. En. S.p.A. (Italy), Hoahai Biological Technology (China), REVANCE THERAPEUTICS (U.S.), Lumenis Be Ltd. (Israel), Venus Concept (Canada), Alma Lasers (Israel), Fotona (Slovenia), Aesthetic Biomedical (U.S.), ThermiGen, LLC. (U.S.), R2 TECHNOLOGIES, INC. (A Subsidiary of INNOVATE Corp.) (U.S.), Sensus Healthcare, Inc. (U.S.), Aesthetic Technology Limited (U.K.), DELEO (France), Biotech Italia Srl (France), Medency (Italy), Aerolase Corp. (U.S.), Sciton (U.S.), Image Derm, Inc. (U.S.) and PhotoMedex (U.S.) among others.
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global aesthetic dermatology market is categorized into seven segments: product type, surgery type, treatment type, application, gender, end user, and distribution channel.
- On the basis of product type, global aesthetic dermatology market is segmented into medicines and devices. In 2022, medicines segment is expected to dominate the global aesthetic dermatology market with 63.67% market share due to continuous increasing product approvals in this category.
- On the basis of surgery type, global aesthetic dermatology market is segmented into minimally invasive and non-invasive. In 2022, minimally invasive segment is expected to dominate the global aesthetic dermatology market with 60.65% market share due to increasing preference of minimally invasive procedures among people.
- On the basis of treatment type, global aesthetic dermatology market is segmented into face treatment and body treatment. In 2022, face treatment segment is expected to dominate the global aesthetic dermatology market with 70.31% market share due to the rising demand among people for aesthetic dermatology treatment on face.
- On the basis of application, global aesthetic dermatology market is segmented into skin rejuvenation, skin resurfacing, skin tightening, hair removal, pigmented & vascular lesions, tattoo removal, scar, acne, dyschromia, skin tags, psoriasis, warts, hyperhidrosis, moles and freckles and others. In 2022, skin rejuvenation segment is expected to dominate the global aesthetic dermatology market with 13.49% market share as the products like botox and dermal fillers are being increasingly used for skin rejuvenation purposes.
- On the basis of gender, global aesthetic dermatology market is segmented into female and male. In 2022, female segment is expected to dominate the global aesthetic dermatology market with 89.67% market share due to the increasing awareness among women about the aesthetic treatments.
- On the basis of end user, global aesthetic dermatology market is segmented into clinical laboratories, hospitals, dermatology clinics, surgical centers, spa clinics and others. In 2022, hospitals segment is expected to dominate the global aesthetic dermatology market with 45.90% market share as hospitals are one of the first contact point and the most trustable option for the patients in various countries.
The hospitals segment will dominate the end user segment of the aesthetic dermatology market
The hospitals segment will emerge as the dominating segment under end user with approximately 46% market share. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
- On the basis of distribution channel, global aesthetic dermatology market is segmented into direct tender and retail sales. In 2022, direct tender segment is expected to dominate the global aesthetic dermatology market with 79.51% market share as it is the most convenient way to distributes products such as laser devices and other medicines.
The direct tender segment will dominate the distribution channel segment of the aesthetic dermatology market
The direct tender segment will emerge as the dominating segment distribution channel segment. This is because of the growing number of direct tenders in the market, especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in aesthetic dermatology market: AbbVie Inc. (U.S.), Henry Schein, Inc. (U.S.), Merz Pharma (Germany), Cutera (U.S.), Cynosure. Inc. (A Subsidiary of Hologic, Inc.) (U.S.), Candela Medical (U.S.), Bausch Health Companies Inc. (Canada), Evolus, Inc. (U.S.), Medytox (South Korea), LUTRONIC (South Korea), HUGEL, Inc. (South Korea), El. En. S.p.A. (Italy), Hoahai Biological Technology (China), REVANCE THERAPEUTICS (U.S.), Lumenis Be Ltd. (Israel), Venus Concept (Canada), Alma Lasers (Israel), Fotona (Slovenia), Aesthetic Biomedical (U.S.), ThermiGen, LLC. (U.S.), R2 TECHNOLOGIES, INC. (A Subsidiary of INNOVATE Corp.) (U.S.), Sensus Healthcare, Inc. (U.S.), Aesthetic Technology Limited (U.K.), DELEO (France), Biotech Italia Srl (France), Medency (Italy), Aerolase Corp. (U.S.), Sciton (U.S.), Image Derm, Inc. (U.S.) and PhotoMedex (U.S.).
Market Development
- In March 2021, Bausch Health Companies Inc. and its Solta Medical business announced the launch of the Clear + Brilliant Touch laser that delivers a customized and more comprehensive treatment protocol to patients of all ages and skin types. This product is known as the company's next-generation Clear + Brilliant laser in the U.S
- In October 2020, AbbVie Inc. announced that it had entered into an agreement with Luminera, a privately held; Aesthetics Company based in Israel with a portfolio and pipeline of dermal filler products
Regional Analysis
Geographically, the countries covered in the aesthetic dermatology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in aesthetic dermatology market during the forecast period 2022 - 2029
North America dominates the aesthetic dermatology market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to major key players and well-developed healthcare infrastructure in this region.
Asia-Pacific is estimated to be the fastest growing region in aesthetic dermatology market the forecast period 2022 - 2029
Asia-Pacific, on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing patient pool, rising investment in the healthcare sector, and growing government support.
COVID-19 Impact
The market has suffered because of the COVID-19. The management of appearance and drug compliance are made more difficult by lockdowns and seclusion during pandemics. The industry will also be impacted by the lack of accessibility to medical facilities for standard care and pharmaceutical administration. Social isolation raises stress levels, feelings of hopelessness, and social support, all of which may lead to fewer cosmetic operations being performed during the epidemic.
For more detailed information about the aesthetic dermatology on market report, click here – https://www.databridgemarketresearch.com/pt/reports/global-aesthetic-dermatology-market
